Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Venofer in CKD Patients Intolerant to Other IV Irons
NCT01151592Phase 4Withdrawn
- Sponsor
- American Regent, Inc.
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of iron sucrose in iron deficiency anemia (IDA), sponsored by American Regent, Inc. Primary endpoint: Incidence and severity of adverse events. Status: withdrawn.
02
Drugs
iron sucrose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT01151592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01151592.